US105A - knight - Google Patents
knight Download PDFInfo
- Publication number
- US105A US105A US105DA US105A US 105 A US105 A US 105A US 105D A US105D A US 105DA US 105 A US105 A US 105A
- Authority
- US
- United States
- Prior art keywords
- knight
- printed copy
- specificasion
- finis
- iiiiii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B61—RAILWAYS
- B61F—RAIL VEHICLE SUSPENSIONS, e.g. UNDERFRAMES, BOGIES OR ARRANGEMENTS OF WHEEL AXLES; RAIL VEHICLES FOR USE ON TRACKS OF DIFFERENT WIDTH; PREVENTING DERAILING OF RAIL VEHICLES; WHEEL GUARDS, OBSTRUCTION REMOVERS OR THE LIKE FOR RAIL VEHICLES
- B61F15/00—Axle-boxes
- B61F15/12—Axle-boxes with roller, needle, or ball bearings
- B61F15/16—Axle-boxes with roller, needle, or ball bearings the axle being slidable or tiltable in the bearings
- B61F15/18—Axle-boxes with roller, needle, or ball bearings the axle being slidable or tiltable in the bearings and having springs opposing such movements
Landscapes
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
Description
I. KNIGHT.
Car-Axle Box.
Patented Dec. 15, I836.
, IIIIII August 24, 19.15.
SPECIFICATION A careful Search has been made this day for th original, file or a. printed copy of the same, for the purpose of reproducing the said specificasion "00 form a part of this book, but at this time nothing can be found from which a. reproduction or printed copy can be made.
Finis D. Morris,
Chief of Division'E.
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US105A true US105A (en) | 1836-12-15 |
Family
ID=2060384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US105D Expired - Lifetime US105A (en) | knight |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US105A (en) |
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4483206A (en) * | 1982-11-22 | 1984-11-20 | Marathon Oil Company | Reactor catalyst removal valve |
| WO2014160871A2 (en) | 2013-03-27 | 2014-10-02 | The General Hospital Corporation | Methods and agents for treating alzheimer's disease |
| WO2016100716A1 (en) | 2014-12-18 | 2016-06-23 | Vasant Jadhav | Reversirtm compounds |
| EP3431076A1 (en) | 2009-06-10 | 2019-01-23 | Arbutus Biopharma Corporation | Improved lipid formulation |
| EP3492596A1 (en) | 2007-04-09 | 2019-06-05 | University of Florida Research Foundation, Inc. | Raav vector compositions having tyrosine-modified capsid proteins and methods for use |
| EP3587434A1 (en) | 2008-09-23 | 2020-01-01 | Alnylam Pharmaceuticals Inc. | Chemical modifications of monomers and oligonucleotides with click components for conjugation with ligands |
| EP3699172A2 (en) | 2008-11-10 | 2020-08-26 | Arbutus Biopharma Corporation | Novel lipids and compositions for the delivery of therapeutics |
| WO2021092371A2 (en) | 2019-11-06 | 2021-05-14 | Alnylam Pharmaceuticals, Inc. | Extrahepatic delivery |
| WO2021224873A1 (en) | 2020-05-07 | 2021-11-11 | Grifols Diagnostic Solutions Inc. | Methods and compositions for detecting sars-cov-2 nucleic acid |
| EP3919619A1 (en) | 2015-07-17 | 2021-12-08 | Alnylam Pharmaceuticals, Inc. | Multi-targeted single entity conjugates |
| WO2022011214A1 (en) | 2020-07-10 | 2022-01-13 | Alnylam Pharmaceuticals, Inc. | Circular sirnas |
| WO2022147223A2 (en) | 2020-12-31 | 2022-07-07 | Alnylam Pharmaceuticals, Inc. | 2'-modified nucleoside based oligonucleotide prodrugs |
| WO2022147214A2 (en) | 2020-12-31 | 2022-07-07 | Alnylam Pharmaceuticals, Inc. | Cyclic-disulfide modified phosphate based oligonucleotide prodrugs |
| WO2023283403A2 (en) | 2021-07-09 | 2023-01-12 | Alnylam Pharmaceuticals, Inc. | Bis-rnai compounds for cns delivery |
| WO2023003922A1 (en) | 2021-07-21 | 2023-01-26 | Alnylam Pharmaceuticals, Inc. | Metabolic disorder-associated target gene irna compositions and methods of use thereof |
| WO2023064530A1 (en) | 2021-10-15 | 2023-04-20 | Alnylam Pharmaceuticals, Inc. | Extra-hepatic delivery irna compositions and methods of use thereof |
| WO2023122347A2 (en) | 2021-12-23 | 2023-06-29 | Mirecule, Inc. | Compositions for delivery of polynucleotides |
| EP4276201A2 (en) | 2017-06-07 | 2023-11-15 | Gen-Probe Incorporated | Detecting babesia species nucleic acid in a sample |
| WO2023220744A2 (en) | 2022-05-13 | 2023-11-16 | Alnylam Pharmaceuticals, Inc. | Single-stranded loop oligonucleotides |
| WO2024006999A2 (en) | 2022-06-30 | 2024-01-04 | Alnylam Pharmaceuticals, Inc. | Cyclic-disulfide modified phosphate based oligonucleotide prodrugs |
| WO2024073732A1 (en) | 2022-09-30 | 2024-04-04 | Alnylam Pharmaceuticals, Inc. | Modified double-stranded rna agents |
-
0
- US US105D patent/US105A/en not_active Expired - Lifetime
Cited By (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4483206A (en) * | 1982-11-22 | 1984-11-20 | Marathon Oil Company | Reactor catalyst removal valve |
| EP3492596A1 (en) | 2007-04-09 | 2019-06-05 | University of Florida Research Foundation, Inc. | Raav vector compositions having tyrosine-modified capsid proteins and methods for use |
| EP3587434A1 (en) | 2008-09-23 | 2020-01-01 | Alnylam Pharmaceuticals Inc. | Chemical modifications of monomers and oligonucleotides with click components for conjugation with ligands |
| EP3699172A2 (en) | 2008-11-10 | 2020-08-26 | Arbutus Biopharma Corporation | Novel lipids and compositions for the delivery of therapeutics |
| EP4241767A2 (en) | 2008-11-10 | 2023-09-13 | Arbutus Biopharma Corporation | Novel lipids and compositions for the delivery of therapeutics |
| EP3431076A1 (en) | 2009-06-10 | 2019-01-23 | Arbutus Biopharma Corporation | Improved lipid formulation |
| WO2014160871A2 (en) | 2013-03-27 | 2014-10-02 | The General Hospital Corporation | Methods and agents for treating alzheimer's disease |
| EP3708184A1 (en) | 2013-03-27 | 2020-09-16 | The General Hospital Corporation | Methods and agents for treating alzheimer s disease |
| WO2016100716A1 (en) | 2014-12-18 | 2016-06-23 | Vasant Jadhav | Reversirtm compounds |
| EP3919619A1 (en) | 2015-07-17 | 2021-12-08 | Alnylam Pharmaceuticals, Inc. | Multi-targeted single entity conjugates |
| EP4276201A2 (en) | 2017-06-07 | 2023-11-15 | Gen-Probe Incorporated | Detecting babesia species nucleic acid in a sample |
| WO2021092371A2 (en) | 2019-11-06 | 2021-05-14 | Alnylam Pharmaceuticals, Inc. | Extrahepatic delivery |
| WO2021224873A1 (en) | 2020-05-07 | 2021-11-11 | Grifols Diagnostic Solutions Inc. | Methods and compositions for detecting sars-cov-2 nucleic acid |
| WO2022011214A1 (en) | 2020-07-10 | 2022-01-13 | Alnylam Pharmaceuticals, Inc. | Circular sirnas |
| WO2022147214A2 (en) | 2020-12-31 | 2022-07-07 | Alnylam Pharmaceuticals, Inc. | Cyclic-disulfide modified phosphate based oligonucleotide prodrugs |
| WO2022147223A2 (en) | 2020-12-31 | 2022-07-07 | Alnylam Pharmaceuticals, Inc. | 2'-modified nucleoside based oligonucleotide prodrugs |
| WO2023283403A2 (en) | 2021-07-09 | 2023-01-12 | Alnylam Pharmaceuticals, Inc. | Bis-rnai compounds for cns delivery |
| WO2023003922A1 (en) | 2021-07-21 | 2023-01-26 | Alnylam Pharmaceuticals, Inc. | Metabolic disorder-associated target gene irna compositions and methods of use thereof |
| WO2023064530A1 (en) | 2021-10-15 | 2023-04-20 | Alnylam Pharmaceuticals, Inc. | Extra-hepatic delivery irna compositions and methods of use thereof |
| WO2023122347A2 (en) | 2021-12-23 | 2023-06-29 | Mirecule, Inc. | Compositions for delivery of polynucleotides |
| WO2023220744A2 (en) | 2022-05-13 | 2023-11-16 | Alnylam Pharmaceuticals, Inc. | Single-stranded loop oligonucleotides |
| WO2024006999A2 (en) | 2022-06-30 | 2024-01-04 | Alnylam Pharmaceuticals, Inc. | Cyclic-disulfide modified phosphate based oligonucleotide prodrugs |
| WO2024073732A1 (en) | 2022-09-30 | 2024-04-04 | Alnylam Pharmaceuticals, Inc. | Modified double-stranded rna agents |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US105A (en) | knight | |
| US63A (en) | Kravxiig | |
| US58A (en) | ||
| US59A (en) | Drawijtg | |
| US109A (en) | Erawijtg | |
| US44A (en) | Itraviitg | |
| US103A (en) | Process | |
| US52A (en) | Drawing | |
| US108A (en) | Braving | |
| US28A (en) | Drawing | |
| US55A (en) | Drawing | |
| US49A (en) | Available | |
| US22A (en) | Spbcificatioh | |
| US81A (en) | Erawijjg | |
| US106A (en) | Specipication | |
| USD74133S (en) | Design for a banjo | |
| US434A (en) | Method of attaching glass kbtobs to metallic sockets | |
| US1400A (en) | ||
| USX9697I1 (en) | Stoves, anthracite coal | |
| USD67709S (en) | Design for a cigar lighter or similar article | |
| USD75549S (en) | Design for a watchcase | |
| USX9276I1 (en) | No printed copy op spxcification in | |
| USX9606I1 (en) | Stoves, for carriages | |
| USX105I1 (en) | Search ro | |
| USX8773I1 (en) | Best available copy |